Utilizing tranexamic acid as a starting material, a series of N-hydroxycarboxamides were synthesized in order to seek new histone deacetylase (HDAC) inhibitors. Further structure optimization involving the replacement of the 1, 4-cyclohexylene group with the 1, 4- phenylene group yielded the promising HDAC inhibitors which possess a terminal bicyclic aryl amide.